Eskayef Pharmaceuticals Limited (SK+F), established in 1979 as a subsidiary of SmithKline & French (USA), is one of Bangladesh’s most respected pharmaceutical companies with a strong global presence. Accredited by US FDA, UK MHRA, EU GMP, Brazil ANVISA, SAPHRA, and VMD UK. SK+F operates Bangladesh’s first and only US FDA-approved injectable facility, setting new standards in quality and compliance. Our diverse portfolio spans generics, biosimilars, oncology, hormones, cephalosporins, penicillins, inhalers, penems, topicals, and oral solids. With 35+ years of excellence, we export to 70+ countries worldwide and proudly serve as a trusted global insulin partner of Novo Nordisk.

Website: Click Here

Country: Bangladesh